Evidence map›Paper›PMID 2227942›Full record

ArticleHuman genetics1990

Rapid diagnosis of Miller-Dieker syndrome and isolated lissencephaly sequence by the polymerase chain reaction.

J R Batanian, S A Ledbetter, R K Wolff, Y Nakamura, R White, W B Dobyns, D H Ledbetter

Abstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 1990. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 60 citations in OpenAlex.

  1. Polymorphism analysis of the VNTR locus D17S5 in central Spain.International journal of legal medicine · 1996
    Article
  2. Article
  3. Article
  4. Article
  5. Genetic factors in lissencephaly syndromes: a review.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 1993
    Review
  6. Article
  7. Uniparental disomy for chromosome 16 in humans.American journal of human genetics · 1993
    Article
  8. Article
  9. Article
  10. Population genetics and forensic efficiency data of 4 AMPFLP's.International journal of legal medicine · 1992
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

J R BatanianInstitute for Molecular Genetics, Baylor College of Medicine, Houston, TX 77030.
S A Ledbetter
R K Wolff
Y Nakamura
R White
W B Dobyns
D H Ledbetter
Baylor College of Medicine · USUniversity of Utah · USIndiana University School of Medicine

Funding

MOLECULAR ANALYSIS OF HUMAN CHROMOSOMES 15 AND 17R01HD020619 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI SHAFFER, LISA · 1986 to 1993
–
NICHD NIH HHS HD20619
6 · The paper itself

Abstract

Probe YNZ22 (D17S5) is a highly polymorphic, variable number tandem repeat (VNTR) marker previously shown to be deleted in all patients with the Miller-Dieker syndrome (MDS) but not in patients with isolated lissencephaly sequence (ILS). Primers were constructed to the unique sequence flanking the polymorphic, repetitive region of YNZ22 for amplification by the polymerase chain reaction (PCR). Analysis of 118 normal individuals revealed 12 alleles (differing in copy number of a 70-bp repeat unit) ranging in size from 168 to 938 bp. A retrospective study of eight MDS and six ILS patients was consistent with Southern blot analysis in all cases except one. In the latter, a very large allele (12 copies of the repeat unit) in a patient and her mother failed to amplify on initial attempts, but was successfully amplified by reducing the concentration of genomic DNA used in the reaction. Prospective studies on two MDS and five ILS patients were successfully performed and confirmed in all cases by Southern blot analysis. From the total sample, restriction fragment length polymorphism (RFLP) analysis was fully informative in four of ten MDS patients and showed a deletion in all four cases. Nine of eleven ILS patients were heterozygous and therefore not deleted for YNZ22. Development of primers for additional polymorphic markers in the Miller-Dieker region will lead to a rapid PCR-based diagnostic approach for all MDS and ILS patients. PCR typing of YNZ22 will also facilitate use of this marker in other applications, including genetic linkage, paternity and forensic studies, and analysis of loss of heterozygosity in tumors.

Indexed as

Abnormalities, MultipleAllelesBase SequenceBlotting, SouthernBrainBrain DiseasesChromosomes, Human, Pair 17DNAFemaleGene AmplificationGene FrequencyGenetic MarkersHumansMaleMolecular Sequence DataOligonucleotide ProbesDNAGenetic MarkersOligonucleotide Probes

Identifiers

PMID2227942
OpenAlexW2066461069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.